跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,593 条关于
“M2T-CD33”
全部
2,593
临床试验
1,609
药物
792
机构
7
资讯
185
10个月前
FDA Grants Orphan Drug Designation to Leukogene's M2T-CD33 for Acute Myeloid Leukemia Treatment
10个月前
Aperture Therapeutics Advances CD33-Targeting Antisense Oligonucleotide APRTX-001 for Neurodegenerative Diseases
去年
FDA Clears IND for SystImmune's BL-M11D1 in Relapsed/Refractory AML
10个月前
Senti Bio to Present Updated SENTI-202 Clinical Data at ASH 2025, Showcasing Logic Gate Technology in AML Treatment
去年
GT Biopharma Advances GTB-3650 Phase 1 Trial to Second Cohort Following Promising Immune Activation Signals
去年
Senti Bio's SENTI-202 Shows Promise in Early AML Trial
去年
GT Biopharma Doses First Patient in Phase 1 Trial of GTB-3650 for Hematologic Malignancies
2年前
OrsoBio Secures $67M for Obesity Drugs, Vor Bio's AML Therapy Shows Promise, and More
去年
Senti Bio Receives $1M CIRM Milestone Payment as SENTI-202 CAR-NK Therapy Shows Promising Early Results in Blood Cancers
去年
Novel CAR-NK Cell Therapy and Chemotherapy Combinations Show Promise for Pediatric and Relapsed AML Treatment
第 1 页,共 19 页
上一页
下一页